Abstract
Purpose of the study: Recombinant human erythropoietin (rh-EPO) has been shown to exert tissue protective properties in various experimental models. However, its potential role in the cardiac arrest (CA) setting has not yet been sufficiently elucidated. The purpose of our study was to evaluate the effect of rh-EPO administration in swine model of ventricular fibrillation (VF) CA. The primary goal of our study was to investigate whether rh-EPO exerts any beneficial effect on Return of Spontaneous Circulation (ROSC) rates, while the secondary aim was to assess its impact in the short-term basis of 24-h and 48-h survival.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
